Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: Effects of Metreleptin in Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 trial updating the effects of metreleptin in Type 1 Diabetes mellitus; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metreleptin (metreleptin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Type 1 Diabetes | Phase 1 | Status: TERMINATED | Results posted: 2019-08-28